🔗 Permalink

Inventor profile of:

Manfred MÖWES

City:

Berlin

Country:

Germany

Published Applications:

8

Last publication date:

2018-02-15

Top Assignees for applications by Manfred MÖWES

The entities that hold a legal rights for patent applications filed by inventor MÖWES Manfred:

Bayer Pharma Aktiengesellschaft 4 Berlin, Germany
Bayer Intellectual Property GmbH 1 Monheim, Germany

Recent patent applications by MÖWES Manfred

Manfred MÖWES from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-02-15

US20180044306A1

Chemistry; metallurgy

1,3,4-THIADIAZOL-2-YL-BENZAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAY

#2 | 2018-02-15

US20180042931A1

Human necessities

N-PHENYL-(MORPHOLIN-4-YL OR PIPERAZINYL)ACETAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE WNT SIGNALLING PATHWAYS

#3 | 2018-02-01

US20180028507A1

Human necessities

3-CARBAMOYLPHENYL-4-CARBOXAMIDE AND ISOPHTALAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAY

#4 | 2017-09-28

US20170273980A1

Human necessities

Benzyl substituted indazoles as BUB1 inhibitors

#5 | 2017-04-27

US20170114070A1

Chemistry; metallurgy

INHIBITORS OF THE WNT SIGNALLING PATHWAYS

#6 | 2017-04-20

US20170107212A1

Chemistry; metallurgy

NOVEL COMPOUNDS

#7 | 2016-02-25

US20160052898A1

Chemistry; metallurgy

NOVEL COMPOUNDS

#8 | 2015-03-19

US20150080374A1

Chemistry; metallurgy

Aminoalcohol substituted 2,3-dihydroimidazo[1,2-C]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis

InventorID:

1104391 ⎘